Brief: Medigene Presents Efficient 6-Day Tcr-T Therapy Production Process
27/06/2024 11:31
June 27 (Reuters) - Medigene AG MDG1k.DE :
* MEDIGENE PRESENTS EFFICIENT 6-DAY TCR-T THERAPY PRODUCTION
PROCESS WITH HIGH STEMNESS
* MEDIGENE AG: MDG1015 SCHEDULED FOR IND SUBMISSION IN Q3
2024 AND
CTA SUBMISSION IN Q4 2024
Source text for Eikon: ID:nGNX4mdvQH
Further company coverage: MDG1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million